已收录 268921 条政策
 政策提纲
  • 暂无提纲
SRC kinase-mediated signaling pathways and targeted therapies in breast cancer
[摘要] Breast cancer (BC) has been ranked the most common malignant tumor throughout the world and is also a leading cause of cancer-related deaths among women. SRC family kinases (SFKs) belong to the non-receptor tyrosine kinase (nRTK) family, which has eleven members sharing similar structure and function. Among them, SRC is the first identified proto-oncogene in mammalian cells. Oncogenic overexpression or activation of SRC has been revealed to play essential roles in multiple events of BC progression, including tumor initiation, growth, metastasis, drug resistance and stemness regulations. In this review, we will first give an overview of SRC kinase and SRC-relevant functions in various subtypes of BC and then systematically summarize SRC-mediated signaling transductions, with particular emphasis on SRC-mediated substrate phosphorylation in BC. Furthermore, we will discuss the progress of SRC-based targeted therapies in BC and the potential future direction.
[发布日期] 2022-12-17 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Breast cancer;SRC kinase;Signaling transduction;Tyrosine phosphorylation;Targeted therapy [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文